相关实验视频

Updated: Sep 17, 2025

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

超染色白血病:新疗法进展和新兴研究方向

Marije A B C Asbreuk^1,2,3, Daphne H Schoenmakers^1,2,3, Laura Ann Adang^4,5

¹Department of Child Neurology, Emma's Children's Hospital, Amsterdam UMC location Vrije Universiteit, the Netherlands.

|June 27, 2025

概括

超染色性白血病 (MLD) 研究的进展为基因疗法等新疗法提供了新的治疗方法. 通过新生儿查 (NBS) 早期诊断对于在症状出现之前进行有效治疗至关重要,以改善患者的治疗结果.

科学领域:

遗传学和罕见疾病.
神经科学是一个神经科学.
溶酶体储存障碍溶酶体储存障碍

背景情况:

甲染色白血病 (MLD) 是一种罕见的,遗传的溶酶体储存障碍.
它是由酸硫酸酶A缺乏引起的,导致硫酸盐的积累和神经退行.
多发性慢性病呈现出渐进的运动和认知能力下降,根据发病年龄而异.

研究的目的:

在过去十年中,审查了色白血病研究的最新进展.
探索了解自然历史,疾病机制和治疗策略的进展.
讨论新生儿查对MLD管理的影响.

主要方法:

关于MLD研究的综合文献综述.
对疾病进展和治疗结果的临床数据的分析.
评估新兴的治疗方法和诊断工具.

主要成果:

疾病进展受症状类型的影响,认知表现显示较慢的衰退.
同源性造血干细胞移植和基因疗法显示出希望,特别是当在症状前给予时.
新生儿查 (NBS) 正在扩大,为及时的治疗决策提出了挑战.

结论:

包括基因疗法在内的新疗法正在为MLD出现.
通过NBS进行早期检测对于优化治疗疗效至关重要.
解决跨MLD亚型的治疗可访问性和异质性对于改善患者护理至关重要.

更多相关视频

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

相关概念视频

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.